The combined application of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via network pharmacology approach

Author:

Lee Su-Been1,Gupta Haripriya1,Min Byeong-Hyun1,Ganesan Raja1,Sharma Satya Priya1,Won Sung-Min1,Jeong Jin-Ju1,Cha Min-Gi1,Kwon Goo-Hyun1,Jeong Min-Kyo1,Hyun Ji-Ye1,Eom Jung-A1,Park Hee-Jin1,Yoon Sang-Jun1,Choi Mi-Ran1,Kim Dong Joon1,Oh Ki-Kwang1,Suk Ki-Tae1

Affiliation:

1. Hallym University

Abstract

Abstract Non-alcoholic fatty liver disease (NAFLD) is an initial etiology to be developed steatosis, liver fibrosis, cirrhosis, and even hepatocellular carcinoma. However, the noticeable therapeutics were not elucidated completely to dampen the progressive rate involved in NAFLD. In the incomplete project, we combined secondary metabolites (SMs) from gut microbiota (GM) and Hordeum vulgare (HV) as a representative grain with potent NAFLD to exert combinatorial effects via network pharmacology. Hence, we retrieved the SMs of HV from NPASS (Natural product Activity & Species Source Database) and SMs of GM from gutMGene database. Then, targets associated with SMs were identified from both SEA (Similarity Ensemble Approach) and STP (SwissTargetPrediction). The crucial overlapping targets were identified on NAFLD-related targets through Ven diagram plotter. We constructed the protein-protein interaction (PPI) network from the crucial targets and built a bubble plot to identify a key mechanism on NAFLD. Also, we analyzed microbiota or barley – signaling pathways – targets – metabolites (MBSTM) in aspects of combinatorial approach (HV, and GM). To be confirmed a significant SM against NAFLD, we performed Molecular Docking (MD) with Autodock 1.5.6 to verify the affinity between SMs and targets. Finally, drug-likeness and toxicity properties of key SMs were validated via SwissADME and ADMETlab platform. The number of 31 core targets was analyzed by PPI network, the result of which represented JUN as a key target on NAFLD. The key SM bound stably to JUN were Tryptanthrin from HV. On a bubble plot, we identified that Apelin signaling pathway might be an inhibitive mechanism to relieve NAFLD in the combinatorial approach. On the holistic viewpoints, we analyzed MBSTM to obtain components associated with Apelin signaling pathway. As a result, we found the primary GM to fight NAFLD: Microbiota (Eubacterium limosum; Eggerthella sp. SDG-2; Alistipes indistinctus YIT 12060; Odoribacter laneus YIT 12061; Paraprevotella clara YIT 11840; Paraprevotella xylaniphila YIT 11841). The MD provided what the key SM (Dihydroglycitein, 1,3-Diphenylpropan-2-ol, and Acetic) is on each target (HDAC5, NOS1, and NOS2) related directly to Apelin signaling pathway. Overall, these results suggest that combinatorial application could be an effective tactic for ameliorating NAFLD.

Publisher

Research Square Platform LLC

Reference54 articles.

1. D. Nonalcoholic fatty liver disease;Adams LA;Annals of epidemiology,2007

2. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis;Targher G;Journal of hepatology,2016

3. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs;Galatou E;Antioxidants (Basel, Switzerland),2022

4. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria;LeBlanc JG;Microbial Cell Factories,2017

5. Zhang, X., Ji, X., Wang, Q. & Li, J. Z. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein & Cell 2017 9:2 9, 164–177 (2017).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3